Intervention 1: Intervention group: containing 25OHD soft gelatin capsular 1000 IU , Producer: Dishmen. the case group will receive 1000 IUs of 25(OH)D daily for 8 wks. The subjects will receive a bot

2 trials

Sponsors

Tehran University of Medical Sciences

Conditions

COVID-19. SARS-associated coronavirus as the cause of diseases classified elsewhere

Phase 3

Evaluation of the efficacy of oral 25-hydroxyvitamin D3 on COVID-19

RecruitingIRCT20200401046909N1

Tehran University of Medical SciencesCOVID-19. SARS-associated coronavirus as the cause of diseases classified elsewhere

Start: 2020-04-15Target: 260Updated: 2020-06-15

Evaluation of the efficacy of oral 25-hydroxyvitamin D3 on COVID-19

RecruitingIRCT20200401046909N2

Tehran University of Medical SciencesCOVID-19. SARS-associated coronavirus as the cause of diseases classified elsewhere

Start: 2020-04-14Target: 540Updated: 2020-06-15